ST. PETERSBURG, FL, April 16, 2014 (GLOBE NEWSWIRE) -- FutureWorld (OTCQB: FWDG), a U.S. Diversified Holding Company formed to capitalize on the burgeoning technology markets globally, announces the following letter to its shareholders from our Chairman & CEO Sam Talari:
Dear Fellow Shareholders, As the CEO of FutureWorld and HempTech, I would like to update all of our shareholders on our current business and events;
HempTech was started to contribute to this current revolution, which has become a national phenomenon, known as the Cannabis industry. Our business model is simple; offer a turnkey solution to the front-line of this burgeoning industry; the dispensaries, medical outpatient centers and growers. Like any other business, the solutions will eventually contract into one solution singularity. This singularity will provide for a complete solution that is needed by operators in this industry with or without any business background, running profitable ventures free from the shackles of nuances created by bottlenecks. We achieve this solution singularity by developing and partnering with "best-of-breeds" companies and technologies around the globe. We have begun our path by offering sets of solutions that have been tested and proven by other industries throughout the years. We will continue searching out and offering more solutions as we uncover this evolving industry.
So far we have achieved the following;
1- We have acquired equity in Verecis and licensed (exclusive) well tested RFID Enterprise Asset Management System through our relationship with Verecis Corporation. CannaTRAK, as an Enterprise Asset Management System, tracks governance Licensing, Seed Sourcing, cultivation and point of sales of medicinal marijuana. CannaTRAK will utilize the latest in RFID hardware and enterprise grade backend software to track Cannabis all throughout its lifecycle for governance, monitoring and profitability. This package is ready for sale nationally through our direct sales force at HempTech.
2- We have licensed security surveillance solution called "SPIDer" from Infrax Systems marketed to the Cannabis industry. SPIDer (Secure Perimeter Intrusion Detection Network) system is designed to stop theft and malicious attacks on sensitive and expensive marijuana and hemp farm facilities. The SPIDer systems consist of 3 levels of detection to identify intruders and threats in areas that are restricted. We are working on developing SPIDer II with a third party developer which comes with added microwave sensor technology feature from seed to delivery. SPIDer is ready for sale nationally through our direct sales force at HempTech. SPIDer II should be available after completion of the pilot phase.
3- We have licensed wireless agricultural sensor networks for precision agriculture, irrigation systems, and greenhouses, called SmartSense. Our Smart Agriculture models allow monitoring multiple environmental parameters involving a wide range of applications with smart sensors for Leaf Wetness, Atmospheric Pressure, Solar Radiation, Air Temperature / Humidity, Soil Temperature / Moisture, Ultraviolet Radiation and etc. The smart sensor information will be collected and sent via the cloud to the central office for analysis and procedural modifications. Smart sensors and intelligent communication is part of the Internet of Things and agricultural smart sensors would allow efficient cultivation and production while minimizing cost and reducing risks. This package is ready for sale nationally through our direct sales force at HempTech.
4- We have started a division called HempTechRx. The new division will concentrate on Cannabidiol (CBD) -based Pharmaceutical & Nutraceutical products for the wellness and nutritional supplement industry. We believe the industrial hemp oil-based Cannabidiol (CBD) nutritional supplement; wellness and personal care products will become one of the biggest markets nationally. HempTechRx is currently developing relationships to start manufacturing and offering "Hemp" based Cannabidiol (CBD) infused products online. The Hemp extracted cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's, Parkinson's and HIV dementia. We believe Hemp oil will have the biggest market going forward in this burgeoning industry. HempTechRx plans on to be the shortest path to revenue as we work through our other technology based offerings due to inherited sales cycle.
5- HempTech has filed trademark applications with United States Patent and Trademark Office for the following products and services; CaNNaBoX, CannaTRAK, URVAPE, HempTechRx. The trademark applications were filed after thorough review of the availability of the trademarks. We will continue protecting our intellectual properties by filing patent and trademark applications as our business grows.
6- We have strengthened our company by inviting experts on our board of advisors. We will continue to do so as our company evolves.
7- On March 28, 2014 (the "Engagement Date"), the Board of Directors of the Company approved the engagement of DKM Certified Public Accountants ("DKM") as its independent registered public accounting firm for the Company's fiscal year ended March 31, 2014. DKM will audit the consolidated balance sheet of the Company as of March 31, 2014, and the related consolidated statements of operations, stockholders' equity, and cash flows for the year then ending. The audit and the financial reviews will be for the purpose of a complete transparency with Securities and Exchange Commission and the shareholders.
Products and services on development;
1- We are developing our unique automated dispenser in conjunction with manufacturers to build automated state-of-the-art medical dispensaries and storage machines for dispensing medicinal marijuana and CBD-based Pharmaceuticals & Nutraceuticals infused with edible consumable goods; like hard candies, granola, and other food products. The design and development of the CaNNaBoX will be based on current in-house technologies founded on Infrax Systems' core intellectual properties. The design will be based on secure mesh wireless architecture with multi-layered security protocols such as TPM and Elliptical curve. Access to the CaNNaBoX will be controlled by multi-access security points such as biometrics and RFID special access cards. This product is in development stage and should be available after completion of the testing phase.
2- We are in preliminary discussion with manufacturers in designing and manufacturing our unique vaporizer called UR.VAPE. We see these types of products to be the fastest path to revenue as it has become a national phenomenon. We have been studying the current technology and market and with our in-house technological background, we believe we can offer a better product than the competition. We will update our shareholder as we progress through the development process. UR.VAPE will be sold through HempTechRx.
3- We are in discussion with Florida Cannabis based companies to prepare for the vote this November on legalized medical marijuana. Although we are not sure if the bill would pass, we are preparing for the possibility of the passage. We believe, our position in the State would allow us great advantage and expand our revenue potential.
4- We are working through developing a consulting package for growers and dispensaries nationally. The package will be in joint venture with industry experts helping individuals and companies around the development of their legal medical marijuana and medical treatment facilities. This package will include leasing growing equipment, security solution, RFID tracking and compliance solution and back office support.
The Cannabis industry is ever growing and evolving industry. Business models needs to be constantly adjusted and configured based on all moving parts. But we are fortunate to be part of this historical moment in time that patients around the globe will someday have access to a natural plant to alleviate their pains or illnesses without the inherited side effects of synthetic medicines. HempTech will be part of that historical moment creating technologies for the delivery of this miracle plant.
Also due to the recent concerns involving SEC and halted stocks in our industry, transparency, governance and compliance will be our first priority at FutureWorld and HempTech. I will update you, our shareholders, with any tangible development as we progress toward executing our business plan.
Regards,
Sam Talari
About FutureWorld
FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a U.S. Diversified Holding Company, listed on the Over the Counter exchange, which was formed to capitalize on the burgeoning markets and technologies globally. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of burgeoning technologies, such as industrial Hemp, globally through HempTech. HempTech, a subsidiary of FutureWorld, is a technology division catered to the industrial Hemp market. HempTech provides smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal marijuana. Our wireless agricultural smart sensor networks offers precision to the agriculture, irrigation systems, and greenhouses for the global Hemp industry. HempTech is also in development, production and marketing of industrial hemp and legal medicinal marijuana by-products throughout United States. FutureWorld and HempTech do not grow, distribute or sale marijuana. To request further information about FutureWorld, please email us at investors@futureworldenergyinc.com or log onto our website at http://www.futureworldenergyinc.com
Safe Harbor
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.